Cigna’s Evernorth Expands Digital Health Formulary with Addition of Omada MSK by Physera

What You Should Know:

< Evernorth offers a devoted and distinct platform for the. distribution of health solutions geared toward health strategies, companies, and. government organizations-- inclusive of those without Cigna medical insurance coverage. This enables Evernorth to partner deeply with, and supply unequaled and. concentrated support to these groups, all guided by its steadfast commitment to. make healthcare better.. -- Cigna Corporations health services section, Evernorth expands its digital health formulary with the addition of Omada MSK by Physera. To date, health insurance covering more than 20 million. Americans use services from Evernorths Digital Health Formulary to their. members. Strategy sponsors can select to invest and deploy specific services, or. a mix of programs on the platform. In addition to extensive measurement. from doctors, pharmacists, and health research scientists, programs on the. formulary are also evaluated by user-experience professionals. People using programs. on the Digital Health Formulary might also get assistance from expert. pharmacists to further optimize the potential health benefits of the chosen. options. Evernorth Health Services Background. -- Omada MSK by Physera signs up with Omadas existing formulary programs for diabetes avoidance, type 2 diabetes, and hypertension. The musculoskeletal program will be readily available to formulary. customers starting in 2021, giving Omada the broadest variety of programs on the. industry-leading platform. Produced in 2019, the Digital Health Formulary. features options that are assessed and determined on medical efficiency,. interoperability, usability, and scalability. Cigna Corporations health services section Evernorth today revealed the expansion of its industry-first Digital Health Formulary, adding Omada Healths program for at-home physical treatment and personalized coaching for chronic pain to the platform. Omada MSK by Physera joins Omadas. existing formulary programs for diabetes avoidance, type 2 diabetes, and. high blood pressure. Schedule.